Literature DB >> 11728343

Rapid secretion of interleukin-1beta by microvesicle shedding.

A MacKenzie1, H L Wilson, E Kiss-Toth, S K Dower, R A North, A Surprenant.   

Abstract

The proinflammatory cytokine interleukin-1beta (IL-1beta) is a secreted protein that lacks a signal peptide and does not follow currently known pathways of secretion. Its efficient release from activated immune cells requires a secondary stimulus such as extracellular ATP acting on P2X(7) receptors. We show that human THP-1 monocytes shed microvesicles from their plasma membrane within 2-5 s of activation of P2X(7) receptors. Two minutes after such stimulation, the released microvesicles contained bioactive IL-1beta, which only later appeared in the vesicle-free supernatant. We conclude that microvesicle shedding is a major secretory pathway for rapid IL-1beta release from activated monocytes and may represent a more general mechanism for secretion of similar leaderless secretory proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728343     DOI: 10.1016/s1074-7613(01)00229-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  318 in total

1.  Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1α.

Authors:  Yaël Berda-Haddad; Stéphane Robert; Paul Salers; Leila Zekraoui; Catherine Farnarier; Charles A Dinarello; Françoise Dignat-George; Gilles Kaplanski
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.

Authors:  Nishkantha Arulkumaran; Robert J Unwin; Frederick Wk Tam
Journal:  Expert Opin Investig Drugs       Date:  2011-04-21       Impact factor: 6.206

3.  Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes.

Authors:  Cristina Andrei; Paola Margiocco; Alessandro Poggi; Lavinia V Lotti; M R Torrisi; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 4.  IL-1beta: an endosomal exit.

Authors:  Mark D Wewers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

5.  P2X receptor antagonists for pain management: examination of binding and physicochemical properties.

Authors:  Rebecca J Gum; Brian Wakefield; Michael F Jarvis
Journal:  Purinergic Signal       Date:  2011-11-16       Impact factor: 3.765

Review 6.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 7.  Microparticles as mediators and biomarkers of rheumatic disease.

Authors:  David S Pisetsky; Anirudh J Ullal; Julie Gauley; Tony C Ning
Journal:  Rheumatology (Oxford)       Date:  2012-03-07       Impact factor: 7.580

8.  Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3.

Authors:  Debajyoti Datta; Christopher L McClendon; Matthew P Jacobson; James A Wells
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

9.  Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7.

Authors:  Sahil Adriouch; Felix Scheuplein; Robert Bähring; Michel Seman; Olivier Boyer; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Purinergic Signal       Date:  2009-02-21       Impact factor: 3.765

10.  P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.

Authors:  Jonathan W Bowler; R Jayne Bailey; R Alan North; Annmarie Surprenant
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.